AR131282A1 - Compuestos novedosos - Google Patents

Compuestos novedosos

Info

Publication number
AR131282A1
AR131282A1 ARP230103313A ARP230103313A AR131282A1 AR 131282 A1 AR131282 A1 AR 131282A1 AR P230103313 A ARP230103313 A AR P230103313A AR P230103313 A ARP230103313 A AR P230103313A AR 131282 A1 AR131282 A1 AR 131282A1
Authority
AR
Argentina
Prior art keywords
novel compounds
compounds
novel
methods
general formula
Prior art date
Application number
ARP230103313A
Other languages
English (en)
Inventor
Lea Aurelie Bouche
Wolfgang Guba
Georg Jaeschke
Stefanie Katharina Mesch
Anglique Patiny-Adam
Christian Schnider
Jonathan Martin Shannon
Sandra Steiner
Andreas Michael Tosstorff
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of AR131282A1 publication Critical patent/AR131282A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

La invención se refiere a compuestos novedosos que tienen la fórmula general (1) en donde R¹, R², X y W son como se describen en la presente, una composición que incluye los compuestos y métodos para usar los compuestos.
ARP230103313A 2022-12-08 2023-12-06 Compuestos novedosos AR131282A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP22212126 2022-12-08

Publications (1)

Publication Number Publication Date
AR131282A1 true AR131282A1 (es) 2025-03-05

Family

ID=84462879

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230103313A AR131282A1 (es) 2022-12-08 2023-12-06 Compuestos novedosos

Country Status (6)

Country Link
EP (1) EP4630420A1 (es)
JP (1) JP2025540258A (es)
CN (1) CN120303272A (es)
AR (1) AR131282A1 (es)
TW (1) TW202440569A (es)
WO (1) WO2024121184A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
CN121358737A (zh) * 2023-06-03 2026-01-16 成都赜灵生物医药科技有限公司 并哒嗪类化合物及其用途
TW202545527A (zh) 2024-01-16 2025-12-01 英商諾得瑟拉公司 Nlrp3及glp-1a組合療法
WO2025180453A1 (zh) * 2024-02-28 2025-09-04 纽欧申医药(上海)有限公司 哒嗪环衍生物及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022525417A (ja) 2019-03-15 2022-05-13 スカイホーク・セラピューティクス・インコーポレーテッド 異常スプライシングを修正するための組成物および方法
EP4289823A4 (en) * 2021-02-08 2025-02-26 Medshine Discovery Inc. SUBSTITUTED PYRIDAZINE PHENOL DERIVATIVES

Also Published As

Publication number Publication date
TW202440569A (zh) 2024-10-16
CN120303272A (zh) 2025-07-11
WO2024121184A1 (en) 2024-06-13
JP2025540258A (ja) 2025-12-11
EP4630420A1 (en) 2025-10-15

Similar Documents

Publication Publication Date Title
CL2023003312A1 (es) Inhibidores de nlrp3
AR131006A1 (es) Compuestos novedosos
CL2023003154A1 (es) Compuestos heterocíclicos
AR132377A1 (es) Compuestos novedosos
CL2021001330A1 (es) Nuevos compuestos heterocíclicos
CL2022001091A1 (es) Dihidrobenzofurano e inden analogos como inhibidores de sarcómero cardíaco (divisional de solicitud 202001871).
AR130984A1 (es) Compuestos novedosos
AR123424A1 (es) Nuevos compuestos heterocíclicos
CO2023016212A2 (es) Derivados de triazina y su uso en el tratamiento del cáncer
AR131278A1 (es) Compuestos novedosos
CL2022000802A1 (es) Compuestos heterocíclicos de arilmetileno como bloqueadores del canal shaker de potasio kv1.3
AR132456A1 (es) Compuestos novedosos
CL2023002429A1 (es) Derivados novedosos de pirimidin-2-il sulfonamida
CL2022000019A1 (es) Nuevos compuestos heterocíclicos
CR20240203A (es) Compuestos de heteroaril-urea novedosos como inhibidores de kv7.2
CO2025003256A2 (es) Derivados novedosos deuterados de pirimidin-2-il sulfonamida
CL2025000126A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
CL2025000125A1 (es) Compuestos derivados de indolsulfonamida y uso para tratar pérdida de mielina.
CO2024003094A2 (es) Compuesto imidazocíclico y aplicación del mismo
AR133076A1 (es) Compuestos novedosos
AR133375A1 (es) Compuestos novedosos
AR131633A1 (es) Derivados novedosos de pirimidinil sulfonamida
AR132455A1 (es) Compuestos novedosos
AR130168A1 (es) Derivados bicíclicos de tetrahidrotiazepina
AR134215A1 (es) Compuestos de tiazol y métodos de uso